|
At
first, Stan believed that she was simply overusing her inhaler, and
in their defense, the girls accused each other of
"stealing" each others medicine.
Together, they figured out that the difference in
their Albuterol use was not how often they used their
inhalers, but how they carried them. An almost
empty pencil case proved to be far superior to tight
pants pockets.
Realizing
that eventually little girls grow up and trade their
pencil cases for tight jeans, Stan knew it
would be a lot easier to re-invent the inhaler than to change
teenage behavior.
Stan noted that if this problem
had plagued his family then many others were having
the same problem. He searched the internet and
library to see if there was already an inhaler cap
available and soon found no such product
existed, nor was there even any mention of the
problem.
Metaphorically speaking Stan didn't just have to build
a better mouse trap... he had to prove the existence
of mice.
After a number of successful,
but clumsy tries the MDI TriggerGuard was conceived.
A die was cut and initial samples of the guard were
produced. Friends and family began using and
testing the device and discovered that the
"leak" was more prevalent than they imagined
and that the Trigger Guard
was more effective.
On January 16, 2003 a patent application was delivered
to the US patent office in Washington DC. Six
months later an application for Pre Market Approval
was delivered to the FDA. The struggle to bring
the Trigger Guard to market had begun.
In October of 2004, with all necessary documentation
and accreditation in place the MDI TriggerGuard was
successfully launched at Medtrade in Orlando.
Soon a Canadian distributor was appointed, and at
Medtrade 2005 in Atlanta Apex-Carex announced that
they would be bringing the "clip" to
America.
With
European patent and regulatory issues completed, MDI
Trigger Guard is in negotiations for European
distribution. It is still the companies goal
that one day soon every metered dose inhaler be
equipped with an MDI Trigger Guard.
|